Alaunos Therapeutics (TCRT) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $843000.0.
- Alaunos Therapeutics' Accounts Payables rose 8406.11% to $843000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $843000.0, marking a year-over-year increase of 8406.11%. This contributed to the annual value of $516000.0 for FY2024, which is 1623.38% down from last year.
- As of Q3 2025, Alaunos Therapeutics' Accounts Payables stood at $843000.0, which was up 8406.11% from $809000.0 recorded in Q2 2025.
- Alaunos Therapeutics' Accounts Payables' 5-year high stood at $4.2 million during Q1 2021, with a 5-year trough of $365000.0 in Q2 2024.
- In the last 5 years, Alaunos Therapeutics' Accounts Payables had a median value of $843000.0 in 2025 and averaged $1.1 million.
- As far as peak fluctuations go, Alaunos Therapeutics' Accounts Payables surged by 95808.08% in 2021, and later crashed by 8556.09% in 2022.
- Over the past 5 years, Alaunos Therapeutics' Accounts Payables (Quarter) stood at $1.4 million in 2021, then increased by 1.54% to $1.4 million in 2022, then crashed by 55.65% to $616000.0 in 2023, then dropped by 16.23% to $516000.0 in 2024, then soared by 63.37% to $843000.0 in 2025.
- Its last three reported values are $843000.0 in Q3 2025, $809000.0 for Q2 2025, and $831000.0 during Q1 2025.